InvestorsHub Logo
Followers 17
Posts 10840
Boards Moderated 0
Alias Born 03/11/2017

Re: None

Thursday, 07/20/2017 1:52:11 PM

Thursday, July 20, 2017 1:52:11 PM

Post# of 44784
Pluristem and Fukushima Medical University to evaluate PLX-R18 cells for radiation treatment.


Under the deal, Pluristem's PLX-R18 cells will be developed to treat acute radiation syndrome (ARS), as well as other morbidities following radiotherapy in cancer patients.


http://www.pharmaceutical-technology.com/news/newspluristem-fukushima-medical-university-evaluate-plx-r18-cells-radiation-treatment-4744875